Medullary thyroid cancer

被引:26
|
作者
Clayman, GL
El-Baradie, TS
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Natl Canc Inst, Cairo, Egypt
关键词
D O I
10.1016/S0030-6665(02)00136-6
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Medullary thyroid cancer is a rare endocrine neoplasm that arises from the parafollicular C cells. Sporadic and familial (inheritable) forms of this disease exist. An emerging molecular and genetic understanding of this, neoplasm is evolving which m ay impact upon management,including screening and prophylactic treatment. Interdisciplinary evaluation and management including surgeons, endocrinologists, pathologists, radiologists, radiotherapists, and medical oncologists should be sought. Surgery remains the foundation of treatments that offer local and regional control and the potential for cure. Prognosis is variable but stage of disease and age are the main prognostic factors. Molecular genetic predictors of biologic potential remain to be established.
引用
收藏
页码:91 / +
页数:16
相关论文
共 50 条
  • [41] Medullary Thyroid Cancer: It is a pain in the neck?
    Guerrero, Marlon A.
    Lindsay, Sheila
    Suh, Insoo
    Vriens, Menno R.
    Khanafshar, Elham
    Shen, Wen T.
    Gosnell, Jessica
    Kebebew, Electron
    Duh, Quan-Yang
    Clark, Orlo H.
    JOURNAL OF CANCER, 2011, 2 : 200 - 205
  • [42] Medullary thyroid cancer treated by capecitabine
    Labidi, Sana Intidhar
    Gravis, Gwenaelle
    Tarpin, Carole
    Brun, Vincent
    Viens, Patrice
    ANTI-CANCER DRUGS, 2007, 18 (07) : 831 - 834
  • [43] Medullary Thyroid Cancer: Updates and Challenges
    Gild, Matti L.
    Clifton-Bligh, Roderick J.
    Wirth, Lori J.
    Robinson, Bruce G.
    ENDOCRINE REVIEWS, 2023, 44 (05) : 934 - 946
  • [44] Medullary thyroid cancer diagnosis: An appraisal
    Trimboli, Pierpaolo
    Giovanella, Luca
    Crescenzi, Anna
    Romanelli, Francesco
    Valabrega, Stefano
    Spriano, Giuseppe
    Cremonini, Nadia
    Guglielmi, Rinaldo
    Papini, Enrico
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (08): : 1216 - 1223
  • [45] RET mutations and medullary thyroid cancer
    Lin, Chia-Chi
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2011, 110 (11) : 731 - 731
  • [46] Medullary thyroid cancer: a case report
    Lerose, M. A.
    Bonaiuto, E.
    Folliero, C.
    Rizzuto, A.
    Innaro, N.
    Cardona, R.
    Sacco, R.
    GIORNALE DI CHIRURGIA, 2010, 31 (6-7): : 354 - 354
  • [47] Management of advanced medullary thyroid cancer
    Hadoux, Julien
    Pacini, Furio
    Tuttle, R. Michael
    Schlumberger, Martin
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (01): : 64 - 71
  • [48] Cabozantinib for patients with medullary thyroid cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (11): : E444 - E444
  • [49] Medullary thyroid cancer arising in an adenoma
    Harari, A
    Ferrari, C
    Shakir, KMM
    THYROID, 2000, 10 (08) : 725 - 726
  • [50] Vandetanib (Caprelsa) for Medullary Thyroid Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1381): : 3 - 4